U
Skylight Health Group Inc.
SLHGF
$0.00
$0.000.00%
E
Sell
7/7/2023Downgrade
Skylight Health Group Inc. (SLHGF) was downgraded to E+ from D- on 7/7/2023 due to a decline in the volatility index, total return index and growth index.
Skylight Health Group Inc. (SLHGF) was downgraded to E+ from D- on 7/7/2023 due to a decline in the volatility index, total return index and growth index.
D
Sell
3/14/2023Downgrade
Skylight Health Group Inc. (SLHGF) was downgraded to D- from D on 3/14/2023 due to a decline in the total return index.
Skylight Health Group Inc. (SLHGF) was downgraded to D- from D on 3/14/2023 due to a decline in the total return index.
D
Sell
2/23/2023Upgraded
Skylight Health Group Inc. (SLHGF) was upgraded to D from D- on 02/23/2023.
Skylight Health Group Inc. (SLHGF) was upgraded to D from D- on 02/23/2023.
D
Sell
2/8/2023Downgrade
Skylight Health Group Inc. (SLHGF) was downgraded to D- from D on 2/8/2023 due to a substantial decline in the solvency index, total return index and volatility index. Debt to equity increased from 0.62 to 1.24, and the quick ratio declined from 1.15 to 0.7.
Skylight Health Group Inc. (SLHGF) was downgraded to D- from D on 2/8/2023 due to a substantial decline in the solvency index, total return index and volatility index. Debt to equity increased from 0.62 to 1.24, and the quick ratio declined from 1.15 to 0.7.
D
Sell
5/5/2022Upgraded
Skylight Health Group Inc. (SLHGF) was upgraded to D from D- on 05/05/2022.
Skylight Health Group Inc. (SLHGF) was upgraded to D from D- on 05/05/2022.
D
Sell
4/20/2022Downgrade
Skylight Health Group Inc. (SLHG) was downgraded to D- from D on 4/20/2022 due to a noticeable decline in the solvency index, total return index and volatility index.
Skylight Health Group Inc. (SLHG) was downgraded to D- from D on 4/20/2022 due to a noticeable decline in the solvency index, total return index and volatility index.
D
Sell
11/17/2021Upgraded
Skylight Health Group Inc. (SLHG) was upgraded to D from D- on 11/17/2021 due to an increase in the valuation index and total return index.
Skylight Health Group Inc. (SLHG) was upgraded to D from D- on 11/17/2021 due to an increase in the valuation index and total return index.
D
Sell
11/8/2021Downgrade
Skylight Health Group Inc. (SLHG) was downgraded to D- from D on 11/8/2021 due to a decline in the growth index. Earnings per share declined from -$0.0494 to -$0.093, operating cash flow declined 59.81% from -$1.33M to -$2.12M, and EBIT declined 34.95% from -$2.11M to -$2.85M.
Skylight Health Group Inc. (SLHG) was downgraded to D- from D on 11/8/2021 due to a decline in the growth index. Earnings per share declined from -$0.0494 to -$0.093, operating cash flow declined 59.81% from -$1.33M to -$2.12M, and EBIT declined 34.95% from -$2.11M to -$2.85M.
D
Sell
7/17/2020Upgraded
CB2 Insights Inc. (CBIIF) was upgraded to D from D- on 7/17/2020 due to a large increase in the growth index, total return index and volatility index. Operating cash flow increased 98.15% from -$135.5 to -$2.5, earnings per share increased from -$0.0549 to -$0.0081, and EBIT increased 46.2% from -$1.58M to -$852.2.
CB2 Insights Inc. (CBIIF) was upgraded to D from D- on 7/17/2020 due to a large increase in the growth index, total return index and volatility index. Operating cash flow increased 98.15% from -$135.5 to -$2.5, earnings per share increased from -$0.0549 to -$0.0081, and EBIT increased 46.2% from -$1.58M to -$852.2.
D
Sell
5/20/2020Downgrade
CB2 Insights Inc. (CBIIF) was downgraded to D- from D on 5/20/2020 due to a noticeable decline in the growth index and volatility index.
CB2 Insights Inc. (CBIIF) was downgraded to D- from D on 5/20/2020 due to a noticeable decline in the growth index and volatility index.
D
Sell
5/1/2020Upgraded
CB2 Insights Inc. (CBIIF) was upgraded to D from D- on 5/1/2020 due to an increase in the volatility index.
CB2 Insights Inc. (CBIIF) was upgraded to D from D- on 5/1/2020 due to an increase in the volatility index.
D
Sell
1/2/2020Upgraded
CB2 Insights Inc. (CBIIF) was upgraded to D- from E on 1/2/2020 due to an increase in the growth index. EBIT increased 56.08% from -$1.27M to -$558.4, earnings per share increased from -$0.0177 to -$0.0101, and operating cash flow increased 40.19% from -$52 to -$31.1.
CB2 Insights Inc. (CBIIF) was upgraded to D- from E on 1/2/2020 due to an increase in the growth index. EBIT increased 56.08% from -$1.27M to -$558.4, earnings per share increased from -$0.0177 to -$0.0101, and operating cash flow increased 40.19% from -$52 to -$31.1.
E
Sell
10/1/2019Upgraded
CB2 Insights Inc. (CBIIF) was upgraded to E from E- on 10/1/2019 due to an increase in the growth index, solvency index and total return index. Operating cash flow increased 91.96% from -$646.4 to -$52, earnings per share increased from -$0.0236 to -$0.0177, and total revenue increased 13.58% from $2.14M to $2.43M.
CB2 Insights Inc. (CBIIF) was upgraded to E from E- on 10/1/2019 due to an increase in the growth index, solvency index and total return index. Operating cash flow increased 91.96% from -$646.4 to -$52, earnings per share increased from -$0.0236 to -$0.0177, and total revenue increased 13.58% from $2.14M to $2.43M.
E
Sell
7/2/2019None
Skylight Health Group Inc. (SLHGF) was downgraded to E- from U on 07/02/2019.
Skylight Health Group Inc. (SLHGF) was downgraded to E- from U on 07/02/2019.
OTC PK
02/12/2025 11:40AM Eastern
Quotes delayed
